Latest Period
Q4 2025
Security Snapshot
Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) Institutional Ownership
CUSIP: 29405E505
13F Institutional Holders and Ownership History from Q4 2025 to Q1 2026
Institutions Reporting
11
Shares (Excl. Options)
24,171
Price
$3.63
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock, $0.01 par value
- Symbol
- ENVB on Nasdaq
- Shares outstanding
- 1,414,064
- Price per share
- $1.95
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 24,171
- Total reported value
- $87,744
- % of total 13F portfolios
- 0%
- Share change
- +24,171
- Value change
- +$87,744
- Number of holders
- 11
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- ENVB - Enveric Biosciences, Inc. - Common Stock, $0.01 par value is tracked under CUSIP 29405E505.
- 11 institutions reported positions in Q4 2025.
- 3 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 11 to 2 between Q4 2025 and Q1 2026.
- Reported value moved from $87,744 to $33,091.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 11 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 29405E505?
CUSIP 29405E505 identifies ENVB - Enveric Biosciences, Inc. - Common Stock, $0.01 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 29405E505:
Significant Owners of Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Ayrton Capital LLC | 10% | 658,465 | Ayrton Capital LLC | 30 Sep 2025 | ||||
| Lind Global Fund III LP | 10% | $552,346 | 141,265 | Lind Global Fund III LP | 28 Jan 2026 | |||
| INTRACOASTAL CAPITAL, LLC | 5% | 0% | $278,572 | +$155,982 | 71,246 | +127% | Mitchell P. Kopin | 27 Jan 2026 |
As of 31 Dec 2025, 11 institutional investors reported holding 24,171 shares of Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB). This represents 1.7% of the company’s total 1,414,064 outstanding shares.